Details for 2016160476

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON DURCH CD47 VERMITTELTER PHAGOZYTOSE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016160476

EP Publication Number

3056515

E-Number

1120832

Language

PCT Number

Publication Date

17.08.2016 A

17.04.2019 B1

Registration Date

17.04.2019

AT Publication Date

15.05.2019

Application Date

15.01.2009

Registration Number

Priorities

15.01.2008

11324 P

22.08.2008

189786 P

IPC

A61K 39/00 20060101AFI20190206BHEP

Maximum Duration of Protection

15.01.2029

Owner

The Board of Trustees of The Leland Stanford Junior UniversityOffice of The General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

JAISWAL, SiddharthaDepartment of Pathology Massachusetts General Hospital Warren 245 55 Fruit St Boston MA 02114US

WEISSMAN, Irving L.747 Santa Ynez Street Stanford, CA 97305US

JAMIESON, Catriona, Helen M.Moores University of California San Diego Cancer Center, MC 0820, 3855 Healty Science Drive La Jolla, CA 92093-0820US

MAJETI, RavindraStanford Institute for Stem Cell Bio and Regenerative Medicine 1050 Arastradero Road Building A Stanford, CA 94304US

Information about Fees